ALPHAGAN(BRIMONIDINE TARTRATE) - 美国FDA药品数据库

与本品相关的专利信息（来自橙皮书Orange Book）
专利号	专利过期日	是否化合物专利	是否产品专利	专利用途代码	专利下载
无
历史专利信息
无

药品注册审批历史信息
申请号	修订号	审批结论	审批日期	审批内容
020613	031	AP	2016/03/23	Labeling Revision
020613	030	AP	2013/06/06	Manufacturing Change or Addition
020613	020	AP	2002/04/12	Manufacturing Change or Addition
020613	019	AP	2002/05/16	Control Supplement
020613	018	AP	2001/12/20	Patient Population Altered
020613	017	AP	2001/12/04	Manufacturing Change or Addition
020613	016	AP	2001/04/12	Manufacturing Change or Addition
020613	015	AP	2001/05/14	Manufacturing Change or Addition
020613	014	AP	2001/04/09	Control Supplement
020613	013	AP	2001/04/09	Manufacturing Change or Addition
020613	012	AP	2001/07/13	Manufacturing Change or Addition
020613	011	AP	2000/10/02	Manufacturing Change or Addition
020613	010	AP	2000/05/26	Control Supplement
020613	008	AP	1999/12/13	Labeling Revision
020613	007	AP	1999/08/26	Control Supplement
020613	006	AP	1999/12/13	Labeling Revision
020613	004	AP	1998/05/20	Manufacturing Change or Addition
020613	003	AP	1998/02/25	Control Supplement
020613	002	AP	1998/01/15	Control Supplement
020613	001	AP	1997/05/29	Control Supplement
020613	000	AP	1996/09/06	Approval